Titoli del Settore Sanitario
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2490 |  PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 9.24 USD | -3.65% | -18.59% | -22.48% | +115.89% | 736.95 M USD | ||
| 2512 |  SLDB Solid Biosciences Inc. - Common Stock | 7.19 USD | +9695.64% | +6.36% | +0.84% | +26.14% | 707.85 M USD | ||
| 2519 |  LMRI Lumexa Imaging Holdings, Inc. - Common Stock | 7.35 USD | -5.53% | -8.35% | -25.98% | -60.59% | 706.19 M USD | ||
| 2532 |  ANRO Alto Neuroscience, Inc. Common Stock | 19.81 USD | -1.54% | -6.78% | -20.63% | +661.92% | 695.21 M USD | ||
| 2536 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 0.09 USD | -99.05% | -98.95% | -98.92% | -99.05% | 6.85 M USD | ||
| 2546 |  ZVRA Zevra Therapeutics, Inc. - Common Stock | 11.49 USD | -0.86% | +13.20% | +13.65% | +7.99% | 679.23 M USD | ||
| 2565 |  CRMD CorMedix Inc. - Common Stock | 8.45 USD | +9911.85% | +4.71% | +9.03% | -25.22% | 662.92 M USD | ||
| 2569 |  BVS Bioventus Inc. - Class A Common Stock | 7.93 USD | -6.82% | -15.01% | -21.02% | +22.57% | 662.43 M USD | ||
| 2575 |  DSGN Design Therapeutics, Inc. - Common Stock | 10.47 USD | -0.10% | -4.73% | -22.16% | +176.98% | 653.92 M USD | ||
| 2584 |  TLRY Tilray Brands, Inc. - Common Stock | 5.49 USD | -0.36% | +0.73% | -10.73% | +1207.14% | 639.85 M USD | ||
| 2588 |  PHR Phreesia, Inc. Common Stock | 10.36 USD | +10428.46% | +15.75% | +7.14% | -55.78% | 640.37 M USD | ||
| 2591 |  CSTL Castle Biosciences, Inc. - Common stock | 20.97 USD | -0.52% | +4.22% | -15.20% | -14.79% | 636.02 M USD | ||
| 2594 |  SGP SpyGlass Pharma, Inc. - Common Stock | 0.18 USD | -4.88% | -99.14% | -99.25% | -99.25% | 6.12 M USD | ||
| 2595 |  SIBN SI-BONE, Inc. - Common Stock | 13.87 USD | -1.63% | -5.52% | +5.56% | -27.15% | 615.12 M USD | ||
| 2597 |  PRME Prime Medicine, Inc. - Common Stock | 3.40 USD | -4.23% | +12.96% | 0.00% | +188.14% | 614.10 M USD | ||
| 2598 |  DRUG Bright Minds Biosciences Inc. - common stock | 81.47 USD | -7.49% | -3.38% | -5.82% | +213.47% | 622.09 M USD | ||
| 2599 |  CADL Candel Therapeutics, Inc. - Common Stock | 8.49 USD | +2.29% | +4.43% | +29.62% | +55.49% | 622.06 M USD | ||
| 2618 |  PTCT PTC Therapeutics, Inc. - Common Stock | 73.80 USD | -0.07% | +7.17% | +13.40% | +50.58% | 612.17 M USD | ||
| 2619 |  EIKN Eikon Therapeutics, Inc. - Common Stock | 10.79 USD | -0.46% | -1.91% | +10.67% | -36.72% | 584.16 M USD | ||
| 2620 |  ACRS Aclaris Therapeutics, Inc. - Common Stock | 4.33 USD | -5.04% | -4.20% | -1.37% | +194.56% | 604.74 M USD |
Notizie Titoli del Settore Sanitario
Teleflex prezza un’offerta di obbligazioni senior da $500 milioni al 5,875%
Bausch + Lomb Corporation (BLCO) Discusses Project Halo and Myopia Control Developments in Vision Care Transcript
Perché il titolo Fulcrum Therapeutics crolla nel dopo-borsa?
Abivax inverte la rotta: titolo giù del 40% nonostante dati positivi
Wolfe Research avvia copertura su Repligen con rating outperform
Wolfe Research avvia la copertura di Waters con rating Outperform
Wolfe Research avvia copertura su Stevanato con rating Outperform
Gainers Titoli del Settore Sanitario
 EWTX Edgewise Therapeutics, Inc. - Common Stock | 40.26 | +11685.71% |
 MBIO Mustang Bio, Inc. - Common Stock | 0.77 | +11392.54% |
 PMI Picard Medical, Inc. Common Stock | 0.17 | +11233.33% |
 HYPD Hyperion DeFi, Inc. - Common Stock | 3.86 | +10928.57% |
 CLYM Climb Bio, Inc. - Common Stock | 11.80 | +10666.42% |
 ADGM Adagio Medical Holdings, Inc - Common Stock | 0.77 | +10594.44% |
 ORIC Oric Pharmaceuticals, Inc. - Common Stock | 8.98 | +10527.22% |
 PIII P3 Health Partners Inc. - Class A Common Stock | 12.91 | +10499.34% |
